“I think it’s really important that people keep signing up to these type of trials to push research forward.”
A trial of nivolumab after surgery for urothelial cancer (urinary tract cancer) (CA209-274)
This trial is for people with a high risk of their urinary tract cancer coming back after surgery.
The urinary tract includes the:
- centre of the
- tube that takes urine from the kidney to the bladder (ureter)
- tube that drains urine from the bladder and out of the body (
The lining of the urinary tract is called the
More about this trial
Surgery is the usual treatment for cancer of the urothelial tract. You might also have a chemotherapy drug called cisplatin before or after surgery.
Some people have a higher risk of their cancer coming back. So doctors are looking for way to improve treatment for people in this situation. In this trial they are looking at a drug called nivolumab.
Please note, the trial is now only open to people who have bladder cancer.
The aims of the trial are to:
- find out how well nivolumab works
- find out how safe it is
- learn more about the side effects
Who can enter
The following bullet points list the entry conditions for this trial. Talk to your doctor or the trial team if you are unsure about any of these. They will be able to advise you.
You might be able to join this trial if the following apply.
- You have bladder cancer
- Your cancer has a high risk of coming back because you are not having cisplatin before your surgery and you have
o any size tumour that has spread to the lymph nodes but not to another part of the body or
o a tumour that has grown through the muscle wall but not into the pelvic or abdominal wall or spread to lymph nodes.
And you aren’t suitable to have cisplatin after surgery or you are refusing it
OR you had cisplatin before surgery
o for any size tumour that has spread to the lymph nodes but not to another part of the body or
o for a tumour that has grown through the connective tissue and into the pelvic wall but hasn’t spread to the lymph nodes
The following must also apply.
- You had an operation within 4 months of joining the trial and the surgeon was able to remove all the cancer
- There is no sign of your cancer on a scan
- Most of the cancer cells are a type called transitional cancer cells or urothelial cancer cells
- There is a tissue sample (
biopsy) of your cancer available for the trial team to do some tests
- You are willing to use reliable contraception during treatment and for 6 months after the final dose of nivolumab if you are a woman, or 8 months if you are a man, if there is any possibility you or your partner could become pregnant
- You have satisfactory blood test results
- You are at least 18 years old
You cannot join this trial if any of these apply. You
- Have had part of your bladder removed for bladder cancer or part of your kidney removed for cancer that started in the middle of the kidney (the renal pelvis)
- Have had surgery to remove a urinary tract cancer and then had a treatment that affects your whole body (systemic treatment) or radiotherapy for either urinary tract cancer or prostate cancer
- Have had any anti cancer treatment including chemotherapy, radiotherapy, biological therapy or experimental treatment within 28 days of starting treatment in this trial
- Have had any other cancer in the last 3 years, unless it was a very early stage and has been successfully treated
- Have an
autoimmune diseaseunless it is vitiligo, type 1 diabetes, thyroid problems that are controlled by medications or a skin condition called psoriasis that doesn’t need systemic treatment
- Have side effects from past treatment apart from minor kidney damage, numbness and tingling in your hands or feet (peripheral neuropathy), hearing loss, hair loss or tiredness (fatigue)
- Have had a severe allergic reaction to monoclonal antibodies or
immunotherapyin the past
- Are allergic to nivolumab or anything it contains
- Have taken steroids in the last 2 weeks to dampen down your immune system apart from inhalers, cream or steroids to replace hormones in the body
- Have had had major surgery in the last 4 weeks or minor surgery such as a biopsy in the last 3 days
- Have hepatitis B or hepatitis C
- Have HIV or AIDS
- Have any other serious medical condition or mental health problem that the trial team think could affect you taking part
- Are pregnant or breastfeeding
- dummy drug (
Neither you nor your doctor can decide which group you are in.
You have nivolumab as a drip into a vein every 2 weeks. It takes about 30 minutes.
You continue to have nivolumab for up to a year as long as it is helping you and the side effects aren’t too bad.
Quality of life
The trial team will ask you to fill out a questionnaire before you start treatment and at set times during treatment. The questionnaire will ask about side effects and how you’ve been feeling. This is called a quality of life study.
You have some extra blood tests as part of this trial. The researchers want to find out what happens to nivolumab in the body.
They will also look for substances called
You may also need to give a tissue sample (biopsy) of your cancer before you start treatment. This is to check if there is a marker on your cancer called PD-L1.
If you already had a tissue sample of your cancer taken either when you were diagnosed or during treatments, the trial team will ask to use some of it.
You’ll see the doctors and have some tests before you start treatment. The tests include:
- CT scan or MRI scan
- physical examination
- a test to look inside your bladder (a
- blood and urine tests
You go to hospital every 2 weeks to have treatment. You see the trial team for a check up and some blood and urine tests.
You have a test to look inside your bladder (a cystoscopy) every 3 months (unless you have had your bladder removed).
When you stop treatment you see the trial team after:
- 1 month
- 3 months
The trial team continue to follow you up every 3 months to see how you are getting on. They will phone you or see you at a routine hospital appointment.
You have a CT or MRI scan every:
- 3 months for 2 years
- 4 months for the next 2 years
- 6 months in the 5th year
How to join a clinical trial
Professor Robert Huddart
Experimental Cancer Medicine Centre (ECMC)